Zydus Cadila gets DCGI approval for human clinical trials of COVID-19 vaccine
Zydus Cadila Healthcare has received approval from the Drugs Controller General of India (DCGI) for human clinical trials, informed government sources.
Glenmark opposes US price-fixing charge
MUMBAI: Glenmark Pharma, charged by US Department of Justice (DoJ) for conspiring to fix prices of generic drugs in US, said on Thursday it will...
Mylan gets go-ahead to make remdesivir
New Delhi: After Hetero and Cipla, another pharmaceutical major Mylan was given permission by India's drug regulator on Thursday to manufacture and market the...
Scottish firm to trial T cells as possible COVID-19 treatment
A Scottish biotechnology firm said it would start clinical trials on a possible T cell treatment for COVID-19, aimed at reducing the...
Emcure Pharma launches generic drug for chronic kidney disease
New Delhi: Emcure Pharmaceuticals on Wednesday said it has launched generic version of sucroferric oxyhydroxide tablets, indicated for the control of increased serum phosphorus levels in...
Alembic gets USFDA nod for generic Doxycycline Hyclate tablets
New Delhi: Drug firm Alembic Pharmaceuticals on Wednesday said it has received nod from the US health regulator for generic Doxycycline Hyclate tablets used for the...
Desmania launches full face mask ‘AARMR’
AARMR, the Full Face Mask is a simple and affordable mask that has 3 times efficacy of the normal mask. To counter this pandemic,...
Hetero to supply 20,000 vials of Remdesivir across India
Following the approval of COVIFOR, the generic of Remdesivir by DCGI, Hetero Healthcare, is set to deliver the first set of 20,000...
Price of Remdesivir for COVID-19 under Rs. 5,000: Cipla
BENGALURU: Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc's antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66),...
Alembic gets tentative USFDA nod for generic Rivaroxaban tablets
Alembic Pharmaceuticals said it has received tentative approval from the US health regulator for its generic version of Rivaroxaban tablets used in...
Hetero announces launch of generic remdesivir
Announcing that it has received manufacturing and marketing approval for remdesivir from the DCGI for the treatment of COVID-19, Hetero has also...
Unichem, Lupin recall hypertension medicines
Unichem Laboratories and Lupin are separately recalling certain batches of drugs from the US market due to quality issues.
COVID-19 drug launched: Glenmark
NEW DELHI: Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild...
Novartis stops HCQ trial against COVID-19
Novartis informed that it is stopping its trial of hydroxychloroquine (HCQ) against COVID-19 due to shortage of participants.
The...
Aleor gets USFDA nod for Adapalene Gel USP
Alembic Pharmaceuticals has announced that its joint venture Aleor Dermaceuticals has received approval from the US Food & Drug Administration (USFDA) for...
Glenmark gets USFDA nod for Fingolimod capsules
New Delhi: Drug major Glenmark Pharmaceuticals on Friday said it has received final nod from the health regulator for Fingolimod capsules. The capsules are used...
Optimus launches COVID-19 drug Favipiravir
Optimus Pharma, a fast growing pharmaceutical company based in Hyderabad, has successfully developed and started commercial exports of the Favipiravir formulation, currently...
Alembic gets USFDA nod for generic Deferasirox tablets
New Delhi: Alembic Pharmaceuticals on Tuesday said it has received final approval from the US health regulator for generic Deferasirox tablets used...
Trends Pharma launches disinfectant tablet
Trends Pharma announced the launch of Sanitab, a multipurpose, non-alcohol based effervescent disinfectant tablet. Approved by the EPA against COVID-19, the formulations...
AstraZeneca strikes deal with Europe’s Inclusive Vaccines
Pharma giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental...
Authors
